MedPath

Lupin Research Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study to Evaluate the Effect of a Contraceptive Vaginal Ring LSP- 5415 on Ovarian Function in Healthy Adult Females

Phase 2
Completed
Conditions
Pregnancy Prevention
Interventions
First Posted Date
2022-05-04
Last Posted Date
2023-03-09
Lead Sponsor
Lupin Research Inc
Target Recruit Count
26
Registration Number
NCT05360550
Locations
🇮🇳

Site 01, Mahape, Mumbai, India

An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study

Phase 2
Completed
Conditions
Pregnancy Prevention
Interventions
Drug: LSP-5415 (etonogestrel/ethinyl estradiol vaginal ring)
First Posted Date
2022-05-04
Last Posted Date
2022-07-19
Lead Sponsor
Lupin Research Inc
Target Recruit Count
40
Registration Number
NCT05360576
Locations
🇮🇳

Site 01, Mahape, Mumbai, India

Evaluate the Safety of a Single Oral Dose of Solosecâ„¢ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV

Phase 4
Completed
Conditions
Bacterial Vaginoses
Interventions
First Posted Date
2019-05-06
Last Posted Date
2020-12-19
Lead Sponsor
Lupin Research Inc
Target Recruit Count
40
Registration Number
NCT03937869
Locations
🇺🇸

Site 1007 - Investigational Research Center, Memphis, Tennessee, United States

🇺🇸

Site 1004 - Investigational Research Center, Long Beach, California, United States

🇺🇸

Site 1006 - Investigational Research Center, Frisco, Texas, United States

and more 6 locations

A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis

Phase 3
Completed
Conditions
Trichomonas Infection
Interventions
Drug: Placebo
First Posted Date
2019-05-02
Last Posted Date
2023-10-04
Lead Sponsor
Lupin Research Inc
Target Recruit Count
147
Registration Number
NCT03935217
Locations
🇺🇸

Site 1006, Virginia Beach, Virginia, United States

🇺🇸

Site 1007, Birmingham, Alabama, United States

🇺🇸

Site 1011, Charleston, South Carolina, United States

and more 8 locations
© Copyright 2025. All Rights Reserved by MedPath